Dutch health services research institute specializing in vaccine effectiveness monitoring, chronic disease management evaluation, and epidemiological surveillance across European care networks.
NIVEL is the Netherlands Institute for Health Services Research, a leading Dutch research centre that studies how healthcare systems deliver care to populations. They specialize in monitoring vaccine effectiveness, analyzing chronic disease self-management, and conducting large-scale epidemiological surveillance across European primary care and hospital networks. Their practical contribution lies in turning routine health data and clinical records into evidence that shapes public health policy, clinical guidelines, and healthcare organization across Europe.
Core contributor to I-MOVE-plus, I-MOVE-COVID-19, and PROMISE — all focused on measuring vaccine impact and disease burden through pooled epidemiological studies across European networks.
Led major work in COMPAR-EU (their largest H2020 grant at EUR 1.28M) comparing self-management interventions, and contributed to TO-REACH on healthcare system resilience.
HarmonicSS involved integrative cohort analysis and big data mining; TAXINOMISIS applied computational modeling and omics for patient stratification; COMPAR-EU used network meta-analysis methods.
PanCareFollowUp focused on survivorship care, lifestyle interventions, and clinical guidelines for adult survivors of childhood cancer.
SoNAR-Global built a global social sciences network addressing antimicrobial resistance and infectious disease management through engagement models and One Health approaches.
NIVEL's early H2020 work (2015–2018) centred on clinical data integration and disease-specific research — autoimmune conditions like Sjögren Syndrome, self-management interventions, and vaccine monitoring platforms. From 2019 onward, their focus broadened toward population-level public health challenges: pandemic preparedness (COVID-19 surveillance), RSV immunisation readiness, antimicrobial resistance, and social determinants of health. This shift reflects a move from disease-specific clinical research toward systems-level epidemiological surveillance and health policy readiness.
NIVEL is increasingly positioning itself as a go-to partner for infectious disease surveillance infrastructure and immunisation readiness across Europe, making them a strong fit for future pandemic preparedness and One Health consortia.
NIVEL operates exclusively as a participant — they have never coordinated an H2020 project, preferring to contribute specialist expertise in health services research and epidemiological methods within large consortia. With 161 unique partners across 35 countries, they are a highly networked but non-leading partner, which suggests they are valued for their data infrastructure, methodological rigour, and access to Dutch primary care networks rather than for project management. Working with NIVEL means gaining a reliable, well-connected research partner who brings real-world health system data to the table.
NIVEL has collaborated with 161 unique partners across 35 countries, giving them one of the broadest collaboration networks among European health services research institutes. Their reach extends well beyond Western Europe, with connections spanning the full EU and associated countries.
NIVEL occupies a distinctive niche as a health services research institute — they don't develop drugs or devices, but rather study how healthcare systems perform and how interventions work in real-world settings. Their access to Dutch routine health data and primary care networks gives them a data asset that few academic partners can match. For consortium builders, NIVEL brings the methodological backbone for comparative effectiveness studies, epidemiological surveillance, and health system evaluation that funding agencies increasingly demand.
